{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T05:08:07Z","timestamp":1733461687765,"version":"3.30.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,5]]},"DOI":"10.7759\/cureus.75137","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:11:26Z","timestamp":1733393486000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-MDA5 Positive Juvenile Dermatomyositis With Macrophage Activation Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Alaa S","family":"Mehair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Harjacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-023-00893-w","article-title":"Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature","volume":"21","author":"Chang Y","year":"2023","unstructured":"Chang Y, Shan X, Ge Y. Macrophage activation syndrome in juvenile dermatomyositis: a case report and a comprehensive review of the literature. Pediatr Rheumatol Online J. 2023, 21:106. 10.1186\/s12969-023-00893-w","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00675-w","article-title":"Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review","volume":"20","author":"Stewart JA","year":"2022","unstructured":"Stewart JA, Price T, Moser S, Mullikin D, Bryan A. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol Online J. 2022, 20:16. 10.1186\/s12969-022-00675-w","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.010","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features","volume":"78","author":"Kurtzman DJ","year":"2018","unstructured":"Kurtzman DJ, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol. 2018, 78:776-85. 10.1016\/j.jaad.2017.12.010","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28899","article-title":"Anti-Mi2 antibody positive dermatomyositis with hyper-elevated creatine kinase: a case report","volume":"14","author":"Ohta R","year":"2022","unstructured":"Ohta R, Yoshioka N, Yamane F, Hayashi M, Sano C. Anti-Mi2 antibody positive dermatomyositis with hyper-elevated creatine kinase: a case report. Cureus. 2022, 14:e28899. 10.7759\/cureus.28899","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00595-1","article-title":"Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review","volume":"19","author":"Yeung TW","year":"2021","unstructured":"Yeung TW, Cheong KN, Lau YL, Tse KN. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review. Pediatr Rheumatol Online J. 2021, 19:103. 10.1186\/s12969-021-00595-1","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy105","article-title":"JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis","volume":"141","author":"Ladislau L","year":"2018","unstructured":"Ladislau L, Su\u00e1rez-Calvet X, Toquet S, et al.. JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain. 2018, 141:1609-21. 10.1093\/brain\/awy105","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel A","year":"2021","unstructured":"Nombel A, Fabien N, Coutant F. Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies. Front Immunol. 2021, 12:773352. 10.3389\/fimmu.2021.773352","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317808-anti-mda5-positive-juvenile-dermatomyositis-with-macrophage-activation-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:11:27Z","timestamp":1733393487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317808-anti-mda5-positive-juvenile-dermatomyositis-with-macrophage-activation-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.75137","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,5]]}}}